Exfoliative skin diseases of the neonate are relatively rare but when present require rapid diagnosis and treatment to decrease morbidity and mortality associated with these entities. We present the case of a 795 g premature male infant who developed exfoliative lesions on day of life 66. Skin and blood cultures were obtained and intravenous antibiotics initiated. Results of a Tzanck smear suggested toxic epidermal necrolysis (TEN), so the infant was emergently transferred to a local children's hospital with burn unit capabilities for further care. Further histopathological evaluation of the skin biopsy confirmed the diagnosis of staphylococcal scalded-skin syndrome (SSSS). The desquamation ceased 24 h after the initiation of antibiotic therapy, and the skin lesions resolved within 10 days. We discuss the pathogenesis of SSSS and TEN and highlight the importance of early diagnosis so appropriate treatment can be initiated.
Introduction
Exfoliative skin diseases of the neonate are relatively rare but when present require rapid diagnosis and treatment to decrease morbidity and mortality. The differential diagnosis of exfoliative skin diseases in neonates include congenital forms of erythroderma as well as dermatosis secondary to infection and medications. Of these, the most important to differentiate are staphylococcal scalded-skin syndrome (SSSS) and toxic epidermal necrolysis (TEN).
Differentiation between these two processes is essential because treatment is vastly different.
Case report
A 795 g premature infant was born at 24.5 weeks gestation by precipitous vaginal delivery after a pregnancy complicated by chorioamnionitis with Streptococcus viridans. The mother was previously healthy. She received corticosteroids before delivery. The Apgar scores were 3 and 5 at 1 and 5 min, respectively. The infant was intubated in the delivery room and transported to the neonatal intensive care unit (NICU) for further management. The infant's NICU course was complicated by respiratory distress syndrome that evolved into chronic lung disease, Streptococcus viridans sepsis, patent ductus arteriosus requiring ligation, intraventricular hemorrhage, post-hemorrhagic hydrocephalus, urinary Candidiasis, gastroesophageal reflux and feeding intolerance.
On day of life 66, a 1 Â 1 cm area of desquamation was noted around the infant's nose and mouth (Figure 1 ). At this time, the infant was receiving supplemental oxygen via nasal cannula and fortified enteral feeds via orogastric tube. Medications included erythromycin, ranitidine, aldactazide, budesonide, ipratropium, amphotericin B and iron. A similar lesion appeared around the central line dressing 6 h later. Within 12 h of the appearance of the initial lesion, approximately 30% of the infant's body demonstrated diffuse erythroderma, blistering and sloughing of the epidermis with positive Nikolsky's sign ( Figure 2 ). The oropharynx appeared erythematous but no blisters were present; otherwise, there was no mucosal involvement. The infant had tachycardia and was irritable but afebrile. Skin and blood cultures were obtained, and the infant was started on intravenous vancomycin and cefotaxime.
The consulting dermatologist performed a punch biopsy of a lesion on the right flank to help differentiate SSSS from TEN. The specimen was sent to pathology for evaluation. Tzanck smear of epidermal tissue from the skin biopsy revealed nucleated keratinocytes and inflammatory cells, suggesting that the cleavage plane was at the dermoepidermal junction. These findings were interpreted to indicate a diagnosis of TEN. Because of the infant's extensive skin involvement and the potential for rapid deterioration, the infant was emergently transported to a local children's hospital with burn unit capabilities. Further histopathological evaluation of the skin biopsy completed later that day by a dermatopathologist revealed subcorneal splitting of the epidermis with few acantholytic cells at the cleavage plane and absence of stratum corneum. The dermis contained no inflammatory infiltrate. These latter findings are classic for SSSS. The skin culture eventually grew Staphylococcus aureus whereas the blood cultures remained negative. The progression of the desquamation halted within 24 h of antibiotic initiation. Ten days later, the skin lesions were completely resolved except around the central line site where there was evidence of a small ulcer. The infant was transferred back to our NICU at this time.
Discussion
The differential diagnosis for neonatal exfoliative processes includes epidermolysis bullosa, bullous mastocytosis, chemical burns, bullous impetigo, SSSS and TEN. In this infant, the most likely diagnosis was either SSSS or TEN. SSSS is a desquamative process resulting from exfoliative toxins A (ETA) and B (ETB) produced by Staphylococcus aureus. Both ETA and ETB produce their effect by cleaving the cell adhesion molecule desmoglein1, which leads to the pathologic finding of cleavage of the mid-to upper level epidermis with cuboidal cells, large nuclei and no inflammatory cells. 1, 2 The clinical features of SSSS were first described over a century ago but the disease received little attention until Lyell 3 described a skin eruption that resembled scalded skin and called it TEN. Lyell 3 later determined that exfoliation associated with S. aureus infection occurred within the epidermis whereas exfoliation not associated with staphylococcal infection occurred at the dermoepidermal junction; 4 the former condition was termed SSSS and the latter was termed TEN.
TEN is a life-threatening dermatosis characterized by extensive full-thickness necrosis of the epidermis and mucous membrane involvement. 5 Reported mortality is 30 to 40%, primarily from overwhelming sepsis. The pathogenesis of TEN is unknown but postulated to be immune mediated or secondary to toxic metabolites. The majority of TEN cases are related to an adverse drug reaction. The common culprits include antibiotics, especially sulfonamides, anticonvulsants, non-steroidal anti-inflammatory drugs and allopurinol. 5 The mainstay of therapy for TEN is discontinuation of non-essential medications, aggressive intravenous fluid and nutritional support, specialized skin care, contact precautions and antimicrobial safeguards to prevent secondary infection. 5 Studies in older children and adults suggest that transfer to a facility with burn unit capabilities significantly reduces the mortality associated with TEN. 6 Multiple cases of SSSS have been reported in newborn infants, including several in premature infants. [7] [8] [9] [10] [11] Most of these infants have survived as SSSS is readily treated with antibiotics directed at S. aureus and good skin care to prevent secondary infection. On the other hand, TEN rarely occurs in newborn infants. To the best of our knowledge, there are four reported cases of TEN in the neonatal period. All cases were associated with infection, for which the infants were receiving broad-spectrum antibiotic therapy. None of these infants survived despite maximal therapy. [12] [13] [14] [15] In the case presented, the infant's clinical exam, biopsy results, disease course and the growth of S. aureus from skin swabs all support the diagnosis of SSSS. However, the differentiation between TEN and SSSS was initially difficult. Although there was no blistering of mucosal surfaces, the perioral lesions and erythematous oropharynx suggested mucosal involvement. The infant was receiving medications that have been associated with TEN, and the Tzanck smear findings of full-thickness epidermal sloughing supported the diagnosis of TEN. However, the histopathological evaluation of the biopsy confirmed the diagnosis of SSSS. This case highlights the importance of rapid, accurate interpretation of the skin biopsy in neonatal exfoliative diseases when the diagnosis is not obvious from the clinical exam alone.
